I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 15 studies | 25% ± 5% | |
| CD16-positive, CD56-dim natural killer cell, human | 6 studies | 18% ± 3% | |
| epithelial cell | 4 studies | 29% ± 14% | |
| astrocyte | 4 studies | 21% ± 4% | |
| oligodendrocyte precursor cell | 4 studies | 23% ± 6% | |
| macrophage | 4 studies | 20% ± 3% | |
| oligodendrocyte | 4 studies | 18% ± 1% | |
| natural killer cell | 3 studies | 20% ± 3% | |
| myeloid cell | 3 studies | 20% ± 2% | |
| vein endothelial cell | 3 studies | 23% ± 7% | |
| GABAergic neuron | 3 studies | 31% ± 2% | |
| glutamatergic neuron | 3 studies | 39% ± 4% | |
| endothelial cell of vascular tree | 3 studies | 25% ± 5% | |
| microglial cell | 3 studies | 21% ± 4% |
